Skip to main content
OpenTrials

Clinical trial condition

Metastatic Melanoma and Merkel Cell Carcinoma

Explore clinical trials studying Metastatic Melanoma and Merkel Cell Carcinoma. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Metastatic Melanoma and Merkel Cell Carcinoma trial results

Completed

A Phase I, Exploratory, Intra-patient Dose Escalation Study to Investigate the Preliminary Safety, Pharmacokinetics, and Anti-tumor Activity of Pasireotide (SOM230) s.c.Followed by Pasireotide LAR in Patients With Metastaticmelanoma or Metastatic Merkel Cell Carcinoma

NCT01652547

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +20 more
Locations
  • Novartis Investigative Site Essen, Germany
  • Novartis Investigative Site Lausanne, Switzerland
  • Novartis Investigative Site Zurich, Switzerland
View Trial Details

Related conditions